Table 1.
Characteristics | Total (n = 135) | Treatment groups of antipsychotic drugs |
P* | ||||
---|---|---|---|---|---|---|---|
typical |
atypical |
||||||
haloperidol (n = 30) | fluphenazine (n = 42) | risperidone (n = 25) | olanzapine (n = 25) | clozapine (n = 13) | |||
No. (%) of men | 82 (61.0) | 19 (63.0) | 26 (62.0) | 16 (64.0) | 11 (44.0) | 10 (77.0) | 0.330 |
Age (years; median, IQ)† | 31 (23-43) | 36.5 (22-37) | 38 (27-47) | 24 (20-32) | 27 (22-39) | 33 (27-46) | 0.014‡ |
Age at illness onset (years; median, IQ) | 27 (22-36) | 28 (22-37) | 32.5 (24-41) | 23 (20-28) | 26 (21-34) | 26 (22-29) | 0.007‡ |
Duration of hospitalization (days; median, IQ) | 33 (18.5-58.5) | 30 (14-60) | 25 (11-39) | 33 (26-60) | 46.5 (27-70) | 40 (29-58) | 0.015‡ |
Time to rehospitalization (days; median, IQ) | 775 (333-936) | 735 (242-936) | 805 (661-995) | 768 (524-936) | 825 (352-878) | 762 (71-804) | 0.378‡ |
Dose (mg/d) | 13,5 (6-20) | 7.5 (5-15) | 4 (4-6) | 10 (10-15) | 250 (200-300) | - |
*Mantel-Haenszel test χ2 test.
†IQ – interquartile (25%-75%) range.
‡Man-Whitney U test.